Aytu Biopharma (AYTU) Other financing activities (2013 - 2022)

Aytu Biopharma (AYTU) has 9 years of Other financing activities data on file, last reported at -$51000.0 in Q4 2022.

• On a quarterly basis, Other financing activities changed N/A year-over-year to -$51000.0 in Q4 2022; TTM through Dec 2022 was -$65000.0, a 100.5% decrease from a year earlier, with the FY2022 full-year figure at -$7000.0, down 40.0% from the prior year.
• Other financing activities for Q4 2022 stood at -$51000.0, down from -$13000.0 in the prior quarter.
• Over the last five years, Other financing activities for AYTU reached as high as $9.0 million in Q1 2020 and fell as low as -$51000.0 in Q4 2022.
• Historically, Other financing activities has averaged $1.6 million across 5 years, with a median of $17860.0 in 2018.
• Across the five-year window, Other financing activities surged 3335.07% in 2020 and slumped 116.67% in 2022, its largest moves.
• Year by year, Other financing activities stood at $36720.0 in 2018, then soared by 217.3% to $116514.0 in 2019, then jumped by 3335.07% to $4.0 million in 2020, then slumped by 100.15% to -$6000.0 in 2021, then sank by 750.0% to -$51000.0 in 2022.
• Per Business Quant data, the three most recent Other financing activities figures were -$51000.0 in Q4 2022, -$13000.0 in Q3 2022, and -$1000.0 in Q1 2022.